Updated:
DEFTA Partners
George Hara's DEFTA Partners has backed over 100 early-stage companies globally since the 1980s, now pivoting toward advanced therapeutics and health IT.
DEFTA Partners
DEFTA Partners was founded by George Hara, an archaeologist-turned-entrepreneur who started his first fiber-optics company while a graduate student at Stanford in 1981. The firm emerged from that entrepreneurial experience and has since funded early-stage technology companies across North America, Europe, the Middle East, and Asia. Hara later served as Senior Advisor to Japan's Minister of Finance and held multiple government advisory roles, a public-policy dimension rare among venture investors. The firm's strategy spans venture capital and development-focused investing, blending traditional early-stage technology deals with infrastructure projects in underserved markets. On the venture side, historical bets include the first gene therapy company Viagene, the first antisense therapy company Isis Pharmaceuticals, and the first bioinformatics company Arris Pharmaceuticals. More recent portfolio activity confirms exposure to digital health and medical devices — Aegle Therapeutics secured a US Department of Defense grant to advance its extracellular vesicle therapy for burn patients, and Abilitech Medical launched its wearable orthotic Assist device for arm-mobility support. DEFTA has also collaborated with QuantuMDx on rapid sepsis diagnostics. Geographically, the firm operates from San Francisco and Yokohama and has executed deals in Israel, Bangladesh, and the UK. DEFTA Partners operates through a collection of entities — DEFTA Capital, DEFTA Corporation — with a team spanning business development, finance, and board oversight across the US and Japan. The firm has publicly listed 11 named professionals on its website, led by Group Chairman & CEO George Hara. In Bangladesh, the firm formed bracNet, an internet service provider joint venture with BRAC, the world's largest NGO — highlighting an operating-company model alongside traditional venture holdings. The firm also launched DEFTA Healthcare Technologies, a dedicated vehicle focused on therapeutics and health-ICT convergence, signaling a concentrated sector pivot for the current deployment cycle. The firm's structural differentiator is its unusual blend of venture capital and development-finance DNA within the same group — most peer funds treat these as separate mandates. This architecture allows DEFTA to pursue proprietary, quasi-governmental infrastructure deals in markets like Bangladesh through its relationship with BRAC, while simultaneously placing early-stage bets on biotechnology startups in the US and Europe. The governance model reflects this hybridity, with Japanese and US corporate entities working in parallel under Hara's chairmanship.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
San Francisco
Corporate office
111 Pine Street, Suite 1410, San Francisco, CA 94111, USA
Additional offices
Yokohama, Japan
Principals
George Hara
Group Chairman & CEO
Satoshi Tsubotani
General Manager of Business Development, DEFTA Capital
Takeo Sako
Deputy General Manager of Business Development, DEFTA Capital
Kyoko Watanabe
Managing Director, DEFTA Corporation
Baldev Madahar
CFO, DEFTA Corporation
Masahide Isono
Principal, DEFTA Corporation
Susumu Kaminaga
Board Director, DEFTA Capital
Mikio Tanji
Executive Officer, DEFTA Capital
May Takahashi
Investment & Business Development Manager, DEFTA Corporation
Yoshiko Kumachi-Takaike
Director of the Board, DEFTA Capital
Yoshiyuki Katsuragi
Director of Business Development, DEFTA Capital
Sector focus
Frequently asked questions
Who runs investment decisions at DEFTA Partners?
George Hara, as Group Chairman & CEO, leads the firm's overall investment direction and strategy. The investment and business development functions are managed by a team that includes Satoshi Tsubotani (General Manager), Takeo Sako (Deputy General Manager), and Masahide Isono (Principal), operating from both the San Francisco and Yokohama offices. The firm does not publicly detail investment committee structure or voting protocols.
How does DEFTA Partners source its deal flow?
DEFTA's sourcing model relies on George Hara's long-standing networks in technology and government, particularly in Japan and the US. The firm's dual presence in Silicon Valley and Yokohama provides access to both Western innovation clusters and Asian corporate partnerships. Its unusual relationship with BRAC in Bangladesh also creates proprietary infrastructure and tech-enabled service opportunities that most venture firms never see.
Is DEFTA Partners a single family office or a traditional venture firm?
DEFTA Partners is structured as a private equity and venture capital firm, not a family office. It operates through multiple corporate entities — DEFTA Capital and DEFTA Corporation — and raises external capital for its investment activities. George Hara's entrepreneurial exit and subsequent government advisory roles form the professional foundation, but the firm does not present itself as managing a single family's wealth.
What investment stages does DEFTA Partners target?
The firm focuses on early-stage companies, specifically Seed-stage investments. Its portfolio history includes founding stakes in companies like Viagene and Arris Pharmaceuticals, indicating willingness to back companies at formation. The recent launch of DEFTA Healthcare Technologies suggests continued appetite for nascent therapeutic and health-ICT platforms.
Which sectors does DEFTA Partners explicitly avoid?
DEFTA's public statements do not list explicitly excluded sectors. The stated focus is on information and communication technology, biotechnology, pharmaceuticals, and healthcare, with a recent pivot toward advanced therapeutics and health IT. Sectors outside these domains — such as heavy industry, commodities, or consumer goods — appear absent from their portfolio, but no formal exclusion policy is disclosed.
Does DEFTA Partners participate in fund commitments or only direct deals?
The firm's public materials describe direct investments in over 100 companies, without mention of fund-of-funds commitments or LP positions in other venture firms. The bracNet joint venture in Bangladesh demonstrates a willingness to use operating-company and project-level structures, but evidence of fund investments in third-party managers is not publicly available.
Where does DEFTA Partners' underlying capital come from?
The firm's capital base is not publicly disclosed. George Hara's wealth originated from a successful fiber-optics startup exit in the early 1980s, which provided the initial anchor for DEFTA's activities. The firm operates with a corporate venture structure, suggesting a mix of Hara's personal capital and potentially institutional or corporate limited partners, but no specific LP names are publicly identified.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: